Español
PrintEmail
Decrease (-) Restore Default Increase (+)
In This Section Texas Health Research & Education Institute

Clinical Trials

Disease or Condition   Venous Thromboembolism (VTE)
Title   A Safety and Efficacy Trial Evaluating the Use of Apixaban in the Treatment of Symptomatic Deep Vein Thrombosis and Pulmonary Embolism (Venous Thromboembolism - VTE)
Description   This is a randomized study comparing Lovenox (an FDA approved drug) with Apixaban (an investigational drug) for patients recently diagnosed with a blood clot in their lower extremities or lung. This study is 6 months in length.
IRB Number   Pro361
Inclusion/Notes   INCLUSION:
  • Men and women ages 18 years of age or older.

  • Clinical diagnosis of deep vein thrombosis (DVT) or pulmonary embolism (PE).

EXCLUSION:
  • Patients who are pregnant.

  • Patients who have abnormal liver or kidney blood tests.

  • Patients who currently require long term anti-coagulation medications.

  • Patients who have a bleeding disorder or history of a recent bleeding abnormality.
Status   Completed
Location   Texas Health Presbyterian Dallas
Principal Name    Gary L Weinstein MD
Contact Name   Claire Peterson, RN, BSCN, CCRC
Phone   (214) 345-4121

Online Tools

Locations

Helpful Info

Links